- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07944196
Gut Microbiome Diversity in Adults With Inflammatory and Immune-Mediated Skin Diseases (GUMIDIC)
Studio Sulla diversità Del Microbiota Intestinale Umano in Pazienti Con Patologie Infiammatorie Cutanee
This study will examine whether the gut bacteria of adults with inflammatory or immune-mediated skin diseases differ from those of healthy adults. It will include people with atopic dermatitis, psoriasis, hidradenitis suppurativa, vitiligo, alopecia areata, acne, pemphigus, or bullous pemphigoid, as well as healthy controls.
Participants will provide a stool sample and complete a short food diary. The study team will analyze the bacteria in the samples and compare the results between the disease groups and healthy controls. Participants with a skin disease will be asked to provide a second stool sample and complete follow-up assessments about six months later; healthy controls will provide one sample. The study will also examine whether changes in gut bacteria are related to skin disease severity, diet, and other collected health information.
Studieöversikt
Status
Studietyp
Inskrivning (Beräknad)
Kontakter och platser
Studiekontakt
- Namn: Gianluca Nazzaro, MD
- Telefonnummer: +39 0255035200
- E-post: gianluca.nazzaro@policlinico.mi.it
Studieorter
-
-
-
Milan, Italien, 20122
- Rekrytering
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
-
Kontakt:
- Gianluca Nazzaro, MD
- Telefonnummer: +39 0255035200
- E-post: gianluca.nazzaro@policlinico.mi.it
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Adults aged 18 years or older with one of eight specialist-confirmed inflammatory or immune-mediated skin diseases, plus healthy adult controls without those diseases. Participants are recruited through the Dermatology service at Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico in Milan, Italy.
Beskrivning
Inclusion Criteria:
- Age 18 years or older.
- Able and willing to provide informed consent.
- For patient groups: specialist-confirmed diagnosis of atopic dermatitis, psoriasis, hidradenitis suppurativa, vitiligo, alopecia areata, acne, pemphigus, or bullous pemphigoid.
- For healthy controls: no diagnosis of the skin diseases studied.
Exclusion Criteria:
- Unable to provide informed consent or complete the study procedures.
- Systemic antibiotic treatment within 8 weeks before recruitment or during follow-up.
- Previous intestinal surgery.
- Inflammatory bowel disease, constipation, or diarrhea.
- Long-term alcohol use.
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: CASE_CONTROL
- Tidsperspektiv: PROSPECTIVE
Kohorter och interventioner
Grupp / Kohort |
|---|
|
Atopic Dermatitis
Adults aged 18 years or older with dermatologist-confirmed atopic dermatitis. Participants provide a stool sample and complete study assessments at baseline and about six months later. |
|
Psoriasis
Adults aged 18 years or older with dermatologist-confirmed psoriasis. Participants provide a stool sample and complete study assessments at baseline and about six months later. |
|
Hidradenitis Suppurativa
Adults aged 18 years or older with dermatologist-confirmed hidradenitis suppurativa. Participants provide a stool sample and complete study assessments at baseline and about six months later. |
|
Vitiligo
Adults aged 18 years or older with dermatologist-confirmed vitiligo. Participants provide a stool sample and complete study assessments at baseline and about six months later. |
|
Acne
Adults aged 18 years or older with dermatologist-confirmed acne. Participants provide a stool sample and complete study assessments at baseline and about six months later. |
|
Pemphigus
Adults aged 18 years or older with dermatologist-confirmed pemphigus. Participants provide a stool sample and complete study assessments at baseline and about six months later. |
|
Bullous Pemphigoid
Adults aged 18 years or older with dermatologist-confirmed bullous pemphigoid. Participants provide a stool sample and complete study assessments at baseline and about six months later. |
|
Healthy Controls
Adults aged 18 years or older who do not have the skin diseases studied. Participants provide one stool sample and complete study assessments at baseline. |
|
Alopecia Areata
dults aged 18 years or older with dermatologist-confirmed alopecia areata. Participants provide a stool sample and complete study assessments at baseline and about six months later. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Relative abundance of Bifidobacteriaceae in stool
Tidsram: Baseline (T1)
|
Compare the relative abundance of the bacterial family Bifidobacteriaceae in stool between the combined group of adults with the eight skin diseases studied and healthy controls. Relative abundance is the number of sequences assigned to Bifidobacteriaceae divided by the total number of bacterial sequences. |
Baseline (T1)
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Relative abundance of Enterobacteriaceae in stool in the combined patient group
Tidsram: Baseline (T1)
|
Compare the relative abundance of Enterobacteriaceae in stool between the combined group of adults with the eight skin diseases studied and healthy controls. |
Baseline (T1)
|
|
Relative abundance of Bifidobacteriaceae by skin-disease group
Tidsram: Baseline (T1)
|
Compare stool Bifidobacteriaceae relative abundance between each disease group-atopic dermatitis, psoriasis, hidradenitis suppurativa, vitiligo, alopecia areata, acne, pemphigus, and bullous pemphigoid-and healthy controls. |
Baseline (T1)
|
|
Relative abundance of Enterobacteriaceae by skin-disease group
Tidsram: Baseline (T1)
|
Compare stool Enterobacteriaceae relative abundance between each of the eight disease groups and healthy controls. |
Baseline (T1)
|
|
Change in stool Bifidobacteriaceae and Enterobacteriaceae over time
Tidsram: Baseline (T1) to 6 months (T2)
|
Assess within-person changes in the relative abundance of Bifidobacteriaceae and Enterobacteriaceae between T1 and T2 in participants with skin disease. |
Baseline (T1) to 6 months (T2)
|
|
Associations between gut bacteria and disease-related measures
Tidsram: Baseline (T1) and 6 months (T2)
|
Explore associations between Bifidobacteriaceae and Enterobacteriaceae relative abundance and disease activity scores, psychological impact scores, available routine laboratory markers, dietary intake, and anthropometric measures, as specified in the protocol. |
Baseline (T1) and 6 months (T2)
|
Samarbetspartners och utredare
Samarbetspartners
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
- Genetiska sjukdomar, medfödda
- Autoimmuna sjukdomar
- Immunsystemets sjukdomar
- Infektioner
- Överkänslighet, Omedelbar
- Överkänslighet
- Hudsjukdomar, Papulosquamous
- Hudsjukdomar
- Alopeci
- Hypotrichosis
- Hårsjukdomar
- Bakteriella infektioner
- Bakteriella infektioner och mykoser
- Svettkörtelsjukdomar
- Hudsjukdomar, bakteriell
- Hudsjukdomar, Smittsamma
- Varbildning
- Hudsjukdomar, genetiska
- Hudsjukdomar, eksem
- Akneiforma utbrott
- Talgkörtelsjukdomar
- Hudsjukdomar, Vesikulobulösa
- Dermatit
- Hidradenit
- Medfödda, ärftliga och neonatala sjukdomar och abnormiteter
- Hud- och bindvävssjukdomar
- Alopecia Areata
- Hidradenitis Suppurativa
- Psoriasis
- Dermatit, atopisk
- Acne vulgaris
- Pemphigus
- Pemfigoid, Bullous
Andra studie-ID-nummer
- GUMIDIC
- 6708 (Annan identifierare: Comitato Etico Territoriale Lombardia 3)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .